However, Fex reversed the ameliorative effect of Trp on MS, suggesting that Trp alleviates MS by improving BA metabolism through inhibition of intestinal FXR signaling (P < 0.05) (Fig. 4E to H). The gene discussed is NR1H4; the disease is myeloid sarcoma.